Zymeworks to acquire Theravance Biopharma for $17 per share

June 29, 2026 6:01 AM

Zymeworks Inc. has agreed to acquire Theravance Biopharma, Inc. (NASDAQ: TBPH) for $17.00 per share in cash, representing an equity ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found